Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer

  • MIURA Norimasa
    Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University
  • NAKAMURA Hiroshige
    Department of Thoracic Surgery, Faculty of Medicine, Tottori University
  • SATO Reina
    Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University
  • TSUKAMOTO Tomoe
    Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University
  • HARADA Tomomi
    Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University
  • TAKAHASHI Shunsaku
    Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University
  • ADACHI Youshin
    Department of Thoracic Surgery, Faculty of Medicine, Tottori University
  • SHOMORI Kohei
    Division of Organ Pathology, Faculty of Medicine, Tottori University
  • SANO Akiko
    Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University
  • KISHIMOTO Yosuke
    Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University
  • ITO Hisao
    Division of Organ Pathology, Faculty of Medicine, Tottori University
  • HASEGAWA Junichi
    Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University
  • SHIOTA Goshi
    Division of Molecular and Genetic Medicine, Department of Genetic Medicine and Regenerative Therapeutics, Faculty of Medicine, Tottori University

この論文をさがす

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (30)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ